Back to News
Market Impact: 0.6

AXS Outperforms Industry, Trades at a Discount: How to Play the Stock

AXSTRVACGLAFG
Company FundamentalsAnalyst EstimatesCorporate EarningsMarket Technicals & FlowsCapital Returns (Dividends / Buybacks)Analyst InsightsInvestor Sentiment & Positioning
AXS Outperforms Industry, Trades at a Discount: How to Play the Stock

AXIS Capital (AXS) has outperformed its industry with a 48% gain in the past year and is currently trading at a discount with a forward price-to-book value of 1.51X, below the industry average. The company's shares are trading near their 52-week high, supported by analyst optimism with raised earnings estimates for 2025 and 2026, and a focus on specialty underwriting and expense reduction aiming for a general and administrative ratio below 11% by 2026. With a VGM Score of A and a history of dividend hikes, AXS presents a potential 9.1% upside based on analysts' price targets.

Analysis

AXIS Capital Holdings Limited (AXS) has demonstrated significant market outperformance, with its shares gaining 48% in the past year, substantially exceeding the growth of its industry (19%), the Finance sector (18.4%), and the Zacks S&P 500 composite (9.4%). The insurer, with an $8.13 billion market capitalization and an average three-month trading volume of 0.7 million shares, exhibits attractive valuation metrics; its forward price-to-book value of 1.51X is below the industry average of 1.56X and notably lower than peers such as The Travelers Companies, Inc. (TRV), Arch Capital Group Ltd. (ACGL), and American Financial Group, Inc. (AFG). Technically, AXS shares trade near their 52-week high ($107.19, closing at $103.42 on Monday) and above both their 50-day ($98.92) and 200-day ($90.34) simple moving averages, indicating strong upward momentum. Growth projections are encouraging, with Zacks Consensus Estimates pointing to a 3.4% year-over-year EPS increase in 2025 on 7.8% higher revenues ($6.58 billion), followed by an 8% EPS and 7.8% revenue increase in 2026. This builds on a 67.1% earnings growth over the past five years. Analyst sentiment is optimistic, with all four covering analysts raising 2025 estimates and one raising 2026 estimates in the past 60 days, pushing consensus earnings estimates up by 2.4% for 2025 and 0.5% for 2026. The average analyst price target of $112.38 suggests a 9.1% potential upside. AXS also boasts a superior return on equity of 19% (trailing 12 months) compared to the 7.8% industry average. Strategically, AXS is focusing on specialty underwriting, wholesale insurance, lower middle markets, and specialty reinsurance, while aiming to reduce its general and administrative expense ratio to below 11% by 2026. The company has a strong dividend history, with 18 consecutive years of increases and a current yield of 1.7%, above the industry average of 0.2%. Despite these positive factors and a VGM Score of A, the stock currently carries a Zacks Rank #3 (Hold).